ArticleCurrent medical imaging2025
Multi-scale based Network and Adaptive EfficientnetB7 with ASPP: Analysis of Novel Brain Tumor Segmentation and Classification.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMedical imaging has undergone significant advancements with the integration of deep learning techniques, leading to enhanced accuracy in image analysis. These methods autonomously extract relevant features from medical images, thereby improving the detection and classification of various diseases. Among imaging modalities, Magnetic Resonance Imaging (MRI) is particularly valuable due to its high contrast resolution, which enables the differentiation of soft tissues, making it indispensable in the diagnosis of brain disorders. The accurate classification of brain tumors is crucial for diagnosing many neurological conditions. However, conventional classification techniques are often limited by high computational complexity and suboptimal accuracy. Motivated by these issues, an innovative model is proposed in this work for segmenting and classifying brain tumors. The research aims to develop a robust and efficient deep learning framework that can assist clinicians in making precise and early diagnoses, ultimately leading to more effective treatment planning. The proposed methodology begins with the acquisition of MRI images from standardized medical imaging databases.
methodsSubsequently, the abnormal regions from the images are segmented using the Multiscale Bilateral Awareness Network (MBANet), which incorporates multi-scale operations to enhance feature representation and image quality. A novel classification architecture then processes the segmented images, termed Region Vision Transformer-based Adaptive EfficientNetB7 with Atrous Spatial Pyramid Pooling (RVAEB7-ASPP). To optimize the performance of the classification model, hyperparameters are fine-tuned using the Modified Random Parameter-based Hippopotamus Optimization Algorithm (MRP-HOA).
resultsThe model's effectiveness is verified through a comprehensive experimental evaluation that utilizes various performance metrics and is compared to current state-of-the-art methods. The proposed MRP-HOA-RVAEB7-ASPP model achieves an impressive classification accuracy of 98.2%, significantly outperforming conventional approaches in brain tumor classification tasks. DISCUSSION: The MBANet effectively performs brain tumor segmentation, while the RVAEB7-ASPP model provides reliable classification. The integration of the MRP-HOA-RVAEB7-ASPP model optimizes feature extractions and parameter tuning, leading to improved accuracy and robustness.
conclusionThe integration of advanced segmentation, adaptive feature extraction, and optimal parameter tuning enhances the reliability and accuracy of the model. This framework provides a more effective and trustworthy solution for the early detection and clinical assessment of brain tumors, leading to improved patient outcomes through timely intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.